BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 11253051)

  • 1. Gliomagenesis: genetic alterations and mouse models.
    Holland EC
    Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of mouse glioma models in preclinical trials.
    Hu X; Holland EC
    Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma oncogenesis and animal models of glioma formation.
    Lyustikman Y; Lassman AB
    Hematol Oncol Clin North Am; 2006 Dec; 20(6):1193-214. PubMed ID: 17113459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways triggering glioma cell invasion.
    Salhia B; Tran NL; Symons M; Winkles JA; Rutka JT; Berens ME
    Expert Rev Mol Diagn; 2006 Jul; 6(4):613-26. PubMed ID: 16824034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biology of gliomas].
    Ducray F
    Cancer Radiother; 2008 Nov; 12(6-7):663-8. PubMed ID: 18838326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and malignant progression of human brain tumours.
    Furnari FB; Huang HJ; Cavenee WK
    Cancer Surv; 1995; 25():233-75. PubMed ID: 8718522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
    Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
    Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma models.
    Dai C; Holland EC
    Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity.
    Bigner DD
    Neurosurgery; 1981 Sep; 9(3):320-6. PubMed ID: 6272152
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.
    Fomchenko EI; Holland EC
    Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and genetic profiling in human gliomas.
    Palanichamy K; Erkkinen M; Saia G; Chakravarti A
    Discov Med; 2007 Jun; 7(38):75-81. PubMed ID: 18093469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.
    Wen PY; Kesari S; Drappatz J
    Expert Rev Anticancer Ther; 2006 May; 6(5):733-54. PubMed ID: 16759164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms in gliomagenesis.
    Hulleman E; Helin K
    Adv Cancer Res; 2005; 94():1-27. PubMed ID: 16095998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic signature of adult gliomas and correlation with MRI features.
    Bruzzone MG; Eoli M; Cuccarini V; Grisoli M; Valletta L; Finocchiaro G
    Expert Rev Mol Diagn; 2009 Oct; 9(7):709-20. PubMed ID: 19817555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Understanding in treating gliomas: an adequate experimental model for each question].
    Javerzat S; Bikfalvi A; Hagedorn M
    Bull Cancer; 2005 Jul; 92(7):633-5. PubMed ID: 16123001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
    Kambara H; Okano H; Chiocca EA; Saeki Y
    Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.